From the Cancer Genome Atlas Network, detailed genomic analyses revealed the amplification of programmed death-ligand 1/2 (PD-L1/2) in cervical cancer tissues, supporting the immune checkpoint inhibitors approach [46], and it is related to poor clinical prognosis [47,48,49,50,51]. Here, CD274 is linked to cervical carcinoma.